- SEK10.19bn
- SEK8.97bn
- SEK1.42bn
- 94
- 26
- 74
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 24.08 | ||
| PEG Ratio (f) | 3.69 | ||
| EPS Growth (f) | 6.97% | ||
| Dividend Yield (f) | 2.08% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.91 | ||
| Price to Tang. Book | 6.58 | ||
| Price to Free Cashflow | 28.37 | ||
| Price to Sales | 7.16 | ||
| EV to EBITDA | 20.62 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 23.16% | ||
| Return on Equity | 18.72% | ||
| Operating Margin | 29.76% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 747.08 | 785.11 | 1,103.96 | 1,296.51 | 1,422.72 | 1,568.5 | 1,752 | 13.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -6.82 | +3.1 | +80.22 | -2.56 | +6.85 | +1.12 | +20.56 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Directors
- Peter Rothschild CHM (71)
- Isabelle Ducellier CEO (51)
- David Dangoor NVC (71)
- Alexander Kotsinas EVF (53)
- Urban Strindlov EVP (56)
- Ulrika Kohler EVP (54)
- Sebastian Schroder EVP (47)
- Henrik Nilsson VOP (52)
- Angelika Kjelldorff VPR (51)
- Gianfranco Grompone VPR (45)
- Marika Isberg VPR (47)
- Peter Persson MDR (51)
- Vanessa Rothschild DRC (35)
- Ewa Bjorling IND (60)
- Peter Elving IND (72)
- Maryam Ghahremani IND (40)
- Anthon Jahreskog IND (41)
- Niklas Ringby IND (41)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 2nd, 1990
- Public Since
- January 1st, 1998
- No. of Shareholders
- 12,061
- No. of Employees
- 225
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm- Shares in Issue
- 101,162,310
- Address
- Kungsbroplan 3, STOCKHOLM, 112 27
- Web
- https://sv.biogaia.com/
- Phone
- +46 855529300
- Contact
- Alexander Kotsinas
- Auditors
- Deloitte AB
Upcoming Events for BIOG B
Biogaia AB Annual Shareholders Meeting
Dividend For BIOGb.ST - 4.9500 SEK
Dividend For BIOGb.ST - 1.9500 SEK
Q1 2025 Biogaia AB Earnings Release
Dividend For BIOGY.PK - 0.7023 USD
Q2 2025 Biogaia AB Earnings Release
Q3 2025 Biogaia AB Earnings Release
Similar to BIOG B
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cinclus Pharma Holding publ AB
OMX Nordic Exchange Stockholm
Corline Biomedical AB
OMX Nordic Exchange Stockholm
Dicot Pharma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Biogaia AB share price?
As of Today at 19:36 UTC, shares in Biogaia AB are trading at SEK100.70. This share price information is delayed by 15 minutes.
How has the Biogaia AB share price performed this year?
Shares in Biogaia AB last closed at SEK100.70 and the price had moved by -16.08% over the past 365 days. In terms of relative price strength the Biogaia AB share price has underperformed the FTSE Global All Cap Index by -17.56% over the past year.
What are the analyst and broker recommendations for Biogaia AB?
The overall consensus recommendation for Biogaia AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Biogaia AB dividend yield?
The Biogaia AB dividend yield is 6.85% based on the trailing twelve month period.
Does Biogaia AB pay a dividend?
Last year, Biogaia AB paid a total dividend of SEK6.90, and it currently has a trailing dividend yield of 6.85%.Looking ahead, shares in Biogaia AB are due to go ex-dividend on 2025-05-08 and the next dividend pay date is 2025-05-14.
When does Biogaia AB next pay dividends?
Biogaia AB are due to go ex-dividend on 2025-05-08 and the next dividend pay date is 2025-05-14. The historic dividend yield on Biogaia AB shares is currently 6.85%.
How do I buy Biogaia AB shares?
To buy shares in Biogaia AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Biogaia AB?
As of the previous close price of SEK100.70, shares in Biogaia AB had a market capitalisation of SEK10.19bn.
Where are Biogaia AB shares listed?
Here are the trading details for Biogaia AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: BIOG B
What kind of share is Biogaia AB?
Based on an overall assessment of its quality, value and momentum Biogaia AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Biogaia AB share price forecast for 2025?
The analyst consensus target price for shares in Biogaia AB is SEK165.00. That is 63.85% above the last closing price of SEK100.70.
Analysts covering Biogaia AB currently have a consensus Earnings Per Share (EPS) forecast of SEK3.94 for the next financial year.
Find out moreWhat is the trend in the Biogaia AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biogaia AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +2.27%.
As of the last closing price of SEK100.70, shares in Biogaia AB were trading -12.46% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Biogaia AB PE Ratio?
The Biogaia AB PE ratio based on its reported earnings over the past 12 months is 24.08. The shares last closed at SEK100.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Biogaia AB?
Biogaia AB's management team is headed by:
- Peter Rothschild - CHM
- Isabelle Ducellier - CEO
- David Dangoor - NVC
- Alexander Kotsinas - EVF
- Urban Strindlov - EVP
- Ulrika Kohler - EVP
- Sebastian Schroder - EVP
- Henrik Nilsson - VOP
- Angelika Kjelldorff - VPR
- Gianfranco Grompone - VPR
- Marika Isberg - VPR
- Peter Persson - MDR
- Vanessa Rothschild - DRC
- Ewa Bjorling - IND
- Peter Elving - IND
- Maryam Ghahremani - IND
- Anthon Jahreskog - IND
- Niklas Ringby - IND